Ossur Hf : Q2 Results 2016
(Thomson Reuters ONE) -
Announcement from Össur hf. No. 71/2016
Reykjavík, 21 July 2016
ÖSSUR Q2 RESULTS 2016
Highlights Q2 2016
* Sales amounted to USD 139 million compared to USD 127 million in Q2 2015,
corresponding to local currency growth of 10% and 5% organic growth.
* Gross profit amounted to USD 89 million or 64% of sales, compared to USD 80
million or 63% of sales in Q2 2015.
* EBITDA amounted to USD 25 million or 18% of sales. Adjusted for one-time
expenses, EBITDA amounted to USD 30 million or 22% of sales compared to USD
28 million or 22% of sales in Q2 2015.
* Net profit amounted to USD 15 million or 10% of sales, compared to USD 16
million or 12% of sales in Q2 2015. Net profit is impacted by one-time costs
of USD 4.6 million. Net profit adjusted for one-time expenses grew 10% and
amounted to 13% of sales.
* Cash generated by operations amounted to USD 16 million or 12% of sales,
compared to USD 23 million or 18% of sales in Q2 2015.
* The financial statements for Q2 2016 include the financials of the recently
acquired Touch Bionics.
* Össur acquired 5,325,004 of own shares in Q2 2016 for approximately USD
20.8 million.
Financial Guidance for 2016
The financial guidance for the full year of 2016 is unchanged except for capital
expenditures.
* Sales growth LCY in the range of 7-9%
* Organic sales growth LCY in the range of 3-5%
* Adjusted EBITDA margin in the range of 20-21% of sales
* Capital expenditures 5% of sales (previously 3-4%)
* Effective tax rate around 26%
Jon Sigurdsson, President & CEO, comments:
"We are pleased to deliver a quarter with strong operational results and good
profitability on top of an excellent comparable quarter last year. Americas had
an overall strong quarter with excellent prosthetics sales growth. As we
expected, EMEA had a good quarter after experiencing a soft Q1. Bracing and
supports sales were once again driven by growth of high end innovative products
and prosthetics sales by bionic products as well as newly launched products. In
April we acquired Touch Bionics, a leader in the upper limb bionic prosthetic
market. For the first time we can now offer a complete bionic portfolio to our
customers."
Conference Call
Össur will host a conference call on Friday 22 July 2016 at 9:00 CET/ 7:00
GMT/ 3:00 EDT.
To participate in the call please dial: Europe: + 45 3544 5580, +44 (0)
203 364 5374 or +46 (0) 8 505 564 74,
The United States: + 1 855 753 2230, Iceland: +354 800 7417
Company announcement Össur hf 30.6.2016:
http://hugin.info/133773/R/2030043/755021.pdf
2016 Q2 Investor Presentation:
http://hugin.info/133773/R/2030043/755038.pdf
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Ossur Hf via GlobeNewswire
[HUG#2030043]
Unternehmensinformation / Kurzprofil:
Datum: 21.07.2016 - 22:00 Uhr
Sprache: Deutsch
News-ID 484788
Anzahl Zeichen: 3680
contact information:
Town:
Reykjavik
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 263 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Ossur Hf : Q2 Results 2016"
steht unter der journalistisch-redaktionellen Verantwortung von
Ossur Hf (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
